2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Fimasartan 120mg: new trials by email Literature Review of Fimasartan 120mg trials Research Report on Fimasartan 120mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia Fimasartan 120mg, Atorvastatin 40mg, Placebo for Fimasartan 120mg - Essential Hypertension, Dyslipidemia | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 133 | 2018-01-15 | 2019-11-05 |
| The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension Fimasartan 60mg, Fimasartan 120mg, Candesartan cilexetil - Hypertension | Phase 3 | Completed | Boryung Pharmaceutical Co., Ltd | 290 | 2010-04-01 | 2012-08-24 |
Dyslipidemias (1) · Essential Hypertension (1) · Hypertension (1)
Boryung Pharmaceutical Co., Ltd (2)
South Korea (2)
ShungChull Chae, Doctor´s degree (1)